It was shown that ZHER2 molecules neither induce toxic effects on breast cancer cells [27] or normal lung fibroblast (Figure S6) nor trigger activation of EGFR signaling as the phosphorylation levels of MAPK and AKT were not upregulated after exposure to Affibody (Figure S3). This evidence concerns the gene EGFR and breast cancer.